Millipore Sigma Vibrant Logo

MABF853 Anti-FcgRIV (CD16-2) Antibody, clone 9E9

View This Product on Sigma-Aldrich
MABF853
100 μg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information

      主要スペック表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      MFC, NEUTAHmPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABF853
      DescriptionAnti-FcgRIV (CD16-2) Antibody, clone 9E9
      Alternate Names
      • CD16-2
      • Fcgr4
      • FcgRIV
      • Fc gammaRIV
      • FcgammaRIV
      • Fcgr3a
      • CD16-2
      • Transmembrane receptor CD16-2
      Background InformationTransmembrane receptor CD16-2 (UniProt: Q8R477; also known as CD16-2, Fcgr4, FcgRIV, Fc gammaRIV, FcgammaRIV, Fcgr3a, CD16-2, Transmembrane receptor CD16-2) is encoded by the Fcgr4 (also known as Fcgr3a, Fcrl3) gene (Gene ID: 245256) in murine species. Murine species express three classes of activating IgG Fc receptors, the high affinity receptor FcgRI, the low affinity receptor FcgRIII, and the FcgRIV or CD16-2. CD16-2, a novel mouse receptor that displays significant homology to CD16/FcgRIII. It is a receptor for soluble IgG2a and 2b complexes, but not necessarily for cellular bound IgG2a. CD16-2 is expressed in peripheral blood leukocytes and in spleen, thymus, colon, and intestine. Similar to other activating receptors, CD16-2 possesses a charged residue within its transmembrane domain that is necessary for association with an ITAM (immunoreceptor tyrosine-based activation motif) bearing accessory protein. Both CD16-2 (FcgRIV) and FcgRIII are considered to be essential for mediating type II and type III autoimmune responses via FcRc-LAT-dependent generation of C5a. However, FcgRIII-deficient mice display compensatory enhanced CD16-2 expression that offers protection from lung inflammation and exhibit reduced sensitivity to IgG2a/b-mediated hemolytic anemia. Ref.: Syed, S.N., et al (2009). Eur. J. Immunol. 39(12): 3343-3356; Mechetina, L.V., et al. (2002). Immunogenetics 54(7): 463-468.
      References
      Product Information
      FormatPurified
      PresentationPurified armenian hamster IgG in PBS without azide.
      Quality LevelMQ100
      Applications
      ApplicationThis armenian hamster monoclonal Anti-FcgRIV (CD16-2) Antibody, clone 9E9, Cat. No. MABF853 is validated for use in Flow Cytometry and Neutralization.
      Key Applications
      • Flow Cytometry
      • Neutralizing
      Application NotesFlow Cytometry Analysis: 20 µg/mL from a representative lot, when added prior to APC-conjugated 9E9, blocked the staining of FcgRIV-positive granulocytes and monocytes by APC-conjugated 9E9 (Courtesy of Jeanette Leusen, Ph.D, University Medical Center, Utrecht, Netherlands).

      Flow Cytometry Analysis: A representative lot detected FcgRIV-positive granulocytes and monocytes from wild-type, but not Fcgr4-knockout mice (Nimmerjahn, F., et al. (2010). Proc. Natl. Acad. Sci. U. S. A. 107(45):19396-19401).

      Flow Cytometry Analysis: A representative lot, pre-conjugated with Alexa Fluor® 647, immunostained murine macrophages, neutrophils, dendritic cells, but not FcgRIII-expressing NK cells. Clone 9E9 also stained a FcgRIV-negative, B220-positive peripheral blood cell population (Syed, S.N., et al. (2009). Eur. J. Immunol. 39(12):3343-3356).

      Neutralizing Analysis: A representative lot, when administered (400-500 µg) via i.v. injection prior to anti-RBC 34-3C-IgG2b (50 µg) i.p. injection, prevented anemia (RBC depletion) induction by 34-3C-IgG2b. Clone 9E9 also prevented immunocomplex (IC) challenge-induced alveolar RBC & PMN infiltration in IC-sensitized mice (Syed, S.N., et al. (2009). Eur. J. Immunol. 39(12):3343-3356).

      Neutralizing Analysis: A representative lot suppressed both wild-type and Fcgr1-/Fcgr3-knockout mouse peritoneal macrophages-mediated phogocytosis of red blood cells (RBCs) opsonized with anti-RBC IgG2b, but not anti-RBC IgG2a (Syed, S.N., et al. (2009). Eur. J. Immunol. 39(12):3343-3356).

      Neutralizing Analysis: A representative lot prevented immune complex binding-induced activation of Fcgr3-deficient mouse neutrophils (Jakus, Z., et al. (2008). J. Immunol. 180(1):618-629).

      Neutralizing Analysis: A representative lot, when administered (200 µg) via i.v. injection 30 min prior to anti-platelet 6A6-IgG2a Fc fusion (3.5 µg) injection, reduced the extend of thrombocytopenia (platelet depletion) induction by 6A6-IgG2a (Nimmerjahn, F., et al. (2005). Immunity. 23(1):41-51).
      Biological Information
      ImmunogenRecombinant mouse FcgRIV extracellular domain fused to mouse IgG1 Fc fragment (Nimmerjahn, F., et al. (2005). Immunity. 23(1):41-51).
      Clone9E9
      ConcentrationPlease refer to lot specific datasheet.
      HostArmenian Hamster
      SpecificityClone 9E9 immunostained murine macrophages, neutrophils, dendritic cells, but not FcgRIII-expressing NK cells. Clone 9E9 also stained a FcgRIV-negative, B220-positive peripheral blood cell population (Syed, S.N., et al. (2009). Eur. J. Immunol. 39(12):3343-3356).
      IsotypeIgG
      Species Reactivity
      • Mouse
      Species Reactivity NoteMouse.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • Fcgr4
      • Fcgr3a
      • Fcrl3
      Purification MethodProtein G purified.
      UniProt Number
      Molecular Weight28.39/28.37/28.38 kDa (UniProt Q3TC44/Q8R2R4/Q8R477) calculated.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Flow Cytometry in RAW264.7 cells.

      Flow Cytometry Analysis: 0.1 µg of this antibody detected FcgRIV on the surface of one million RAW264.7 murine macrophages.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      MABF853 04054839156410

      Documentation

      Anti-FcgRIV (CD16-2) Antibody, clone 9E9 (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Anti-FcgRIV (CD16-2) Antibody, clone 9E9 試験成績書(CoA)

      タイトルロット番号
      Anti-FcgRIV (CD16-2), clone 9E9 - 3247502 3247502
      Anti-FcgRIV (CD16-2), clone 9E9 - 3474107 3474107
      Anti-FcgRIV (CD16-2), clone 9E9 - 3782116 3782116
      Anti-FcgRIV (CD16-2), clone 9E9 - 3887049 3887049
      Anti-FcgRIV (CD16-2), clone 9E9 -Q2806308 Q2806308
      Anti-FcgRIV (CD16-2), clone 9E9 Monoclonal Antibody 3146934